Canine intestinal contents vs. simulated media for the assessment of solubility of two weak bases in the human small intestinal contents

被引:134
作者
Kalantzi, Lida
Persson, Eva
Polentarutti, Britta
Abrahamsson, Bertil
Goumas, Konstantinos
Dressman, Jennifer B.
Reppas, Christos [1 ]
机构
[1] Univ Athens, Lab Biopharmaceut & Pharmacokinet, Athens, Greece
[2] AstraZeneca R&D, Preformulat & Biopharmaceut Dept, Molndal, Sweden
[3] Red Cross Hosp Athens, Dept Gastroenterol, Athens, Greece
[4] Univ Frankfurt, Dept Pharmaceut Technol, D-6000 Frankfurt, Germany
[5] Univ Athens, Sch Pharm, Lab Biopharmaceut & Pharmacokinet, GR-15771 Athens, Greece
关键词
canine intestinal fluid; dipyridamole; FaSSIF; FeSSIF; human intestinal fluid; ketoconazole; solubility;
D O I
10.1007/s11095-006-0207-8
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. This study was conducted to assess the relative usefulness of canine intestinal contents and simulated media in the prediction of solubility of two weak bases (dipyridamole and ketoconazole) in fasted and fed human intestinal aspirates that were collected under conditions simulating those in bioavailability/bioequivalence studies. Methods.After administration of 250 mL of water or 500 mL of Ensure plus (R) [both containing 10 mg/mL polyethylene glycol (PEG) 4000 as nonabsorbable marker], intestinal aspirates were collected from the fourth part of the duodenum of 12 healthy adults and from the mid-jejunum of four Labradors. Pooled samples were analyzed for PEG, pH, buffer capacity, osmolality, surface tension, pepsin, total carbohydrates, total protein content, bile salts, phospholipids, and neutral lipids. The shake-flask method was used to measure the solubility of dipyridamole and ketoconazole in pooled human and canine intestinal contents and in fasted-state-simulating intestinal fluid (FaSSIF) and fed-state-simulating intestinal fluid (FeSSIF) containing various bile salts and pH-buffering agents. Results.For both compounds, solubility in canine contents may be predictive of human intralumenal solubility in the fasting state but not in the fed state. The poor agreement of results in canine and human aspirates can be attributed to the higher bile salt content in canine bile. Solubility in FaSSIF containing a mixture of bile salts from crude bile predicted satisfactorily the intralumenal solubility of both drugs in the fasted state in humans. Solubility in FeSSIF, regardless of the identity of bile salts or of the buffering species, deviated from intralumenal values in the fed human aspirates by up to 40%. This was attributed to the lack of lipolytic products in FeSSIF, the higher bile salt content of FeSSIF, and the lower pH of FeSSIF. Conclusions. FaSSIF containing a mixture of bile salts from crude bile, and FeSSIF containing lipolytic products and, perhaps, having lower bile salt content but slightly higher pH, should be more useful than canine intestinal aspirates for predicting intralumenal solubilities in humans.
引用
收藏
页码:1373 / 1381
页数:9
相关论文
共 27 条
[1]   CONTRACTILE MECHANISMS OF GALLBLADDER FILLING AND EMPTYING IN DOGS [J].
ABIRU, H ;
SARNA, SK ;
CONDON, RE .
GASTROENTEROLOGY, 1994, 106 (06) :1652-1661
[2]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[3]  
ARMAND M, 1996, AM J PHYSIOL, V271, P172
[4]   SENSITIVE DETERMINATION OF FREE AND PLASMA PROTEIN-BOUND DIPYRIDAMOLE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
BARBERI, M ;
MERLIN, JL ;
WEBER, B .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1991, 565 (1-2) :511-515
[5]   ELECTRONIC ABSORPTION AND FLUORESCENCE SPECTROSCOPIC STUDIES OF DIPYRIDAMOLE - EFFECTS OF SOLUTION COMPOSITION [J].
BORISEVITCH, IE ;
TABAK, M .
JOURNAL OF LUMINESCENCE, 1992, 51 (06) :315-322
[6]  
BUXTON TB, 1979, GASTROENTEROLOGY, V76, P820
[7]   EFFECT OF PH ON DISINTEGRATION AND DISSOLUTION OF KETOCONAZOLE TABLETS [J].
CARLSON, JA ;
MANN, HJ ;
CANAFAX, DM .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1983, 40 (08) :1334-1336
[8]  
de Zwart L.L., 1999, 623860010 RIVM NAT I
[9]  
Dighe S. V., 1991, PHARM BIOEQUIVALENCE, P235
[10]   Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs [J].
Galia, E ;
Nicolaides, E ;
Hörter, D ;
Löbenberg, R ;
Reppas, C ;
Dressman, JB .
PHARMACEUTICAL RESEARCH, 1998, 15 (05) :698-705